Evolus (EOLS) Gross Profit (2019 - 2026)
Evolus (EOLS) recorded Gross Profit of $50.69 million in Q3 2026, up 10.6% from $45.84 million a year earlier but down 11.4% from the prior quarter.
Powered by 
Analysis
Evolus (EOLS) Gross Profit (2019 - 2026) Analysis & Trends
On a TTM basis, Evolus' Gross Profit came in at $216.05 million as of Sep 30, 2026, up 13.4% year-over-year; for FY2025, it came in at $197.11 million, up 8.1% from FY2024.
- Annual Gross Profit has increased for six straight years, with a five-year compound annual growth rate of 38.8% (FY2020 to FY2025).
- Across earlier years, Gross Profit came in at $182.3 million in FY2024 (+32.5%), $137.57 million in FY2023 (+53.2%), $89.77 million in FY2022 (+59.9%) and $56.14 million in FY2021 (+46.8%).
- Quarterly Gross Profit has ranged from $18.82 million in Q4 2021 to $59.29 million in Q4 2025 over the past five years.
- On a year-over-year basis, Gross Profit has increased for five consecutive quarters, with growth averaging 13.8% over the last eight quarters.
- Peak year-over-year performance for Gross Profit in the last five years was growth of 182.3% in Q1 2022, against a decline of 3.7% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $57.18 million (Q2 2026), $48.9 million (Q1 2026) and $59.29 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Evolus | 450.43 Mn | 259.94 Mn | 50.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 50.69 Mn |
| Jun 30, 2026 | 57.18 Mn |
| Mar 31, 2026 | 48.90 Mn |
| Dec 31, 2025 | 59.29 Mn |
| Sep 30, 2025 | 45.84 Mn |
| Jun 30, 2025 | 45.32 Mn |
| Mar 31, 2025 | 46.66 Mn |
| Dec 31, 2024 | 52.63 Mn |
| Sep 30, 2024 | 42.10 Mn |
| Jun 30, 2024 | 47.07 Mn |
| Mar 31, 2024 | 40.50 Mn |
| Dec 31, 2023 | 38.77 Mn |
| Sep 30, 2023 | 34.59 Mn |
| Jun 30, 2023 | 34.63 Mn |
| Mar 31, 2023 | 29.58 Mn |
| Dec 31, 2022 | 27.32 Mn |
| Sep 30, 2022 | 20.41 Mn |
| Jun 30, 2022 | 21.34 Mn |
| Mar 31, 2022 | 20.70 Mn |
| Dec 31, 2021 | 18.82 Mn |
API Access
Evolus Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=EOLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "EOLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=EOLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();